케이바이오랩스

038530KOSDAQ생활용품 도매업

66.0 / 100

Reference Date: 2026-06-10

Financial Score25.0 / 40

News Sentiment19.0 / 25

Momentum12.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 209.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

KEBIO operates in two main sectors: bio-distribution of life science equipment and reagents, and ICT solutions including hardware, software, and IT services. Since acquiring CureBio's distribution division in 2021, the company has expanded its bio-distribution business, leveraging over 20 years of experience. Additionally, it is broadening its ICT offerings by developing IoT-based security solutions, such as large-scale integrated control systems and smart policing services, building on its expertise in video security technology.

Number of Employees

38people

Average Salary

49.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 10.954.0Point

PBR

0.22Industry Average 0.667.0Point

Half of industry avg (excellent)

ROE

-4.82Industry Average 0.060.0Point

Well below industry avg

Debt Ratio

0.33Industry Average 11.058.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲97.1% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲166.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -8.8% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 4Neutral 1Negative 0Average Sentiment Score 76

Positive
경동제약, 국책과제 선정…“고순도 API 합성 기술로 공급망 안정화”
경동제약의 국책과제 선정으로 케이바이오랩스와 관련된 산업 전반에 긍정적 영향 기대.
Positive
경동제약, 필수의약품 국산화 위한 국책과제 선정 "고순도 API 합성...
케이바이오랩스와 관련 없는 경동제약의 필수의약품 국산화 국책과제 선정으로 인해 제약 산업 전반에 긍정적 영향 예상.
Neutral
롯데벤처스, 그룹 계열사와 협업할 스타트업 10곳 선발
롯데벤처스의 오픈이노베이션 프로그램을 통해 선발된 스타트업들은 케이바이오랩스와 직접적인 연관성이 없어 해당 주식에 대한 직접적인 영향은 제한적이다.

Detailed Momentum

52-week position5.0Point

52w mid range (58%)

Current 960Won52-week high 1,48252-week low 225

1-month return6.0Point

1m +209.68% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral분기보고서 (2026.03)2026-05-15
Neutral[기재정정]분기보고서 (2026.03)2026-05-15